Evidence map›Paper›PMID 21293464›Full record

ArticleNature biotechnology2011

A functionally characterized test set of human induced pluripotent stem cells.

Gabriella L Boulting, Evangelos Kiskinis, Gist F Croft, Mackenzie W Amoroso, Derek H Oakley, Brian J Wainger, Damian J Williams, David J Kahler, Mariko Yamaki, Lance Davidow and 8 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 281 papers.

0numbers the graph read from it
0cells of the map it votes in
281citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

281 citing papers in PubMed.

  1. Injury and therapy in a human spinal cord organoid.Nature biomedical engineering · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Spinal Spheroids as Screening Platform for Peripheral Neuropathies.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

221 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Gabriella L BoultingThe Howard Hughes Medical Institute, Cambridge, Massachusetts, USA.
Evangelos Kiskinis
Gist F Croft
Mackenzie W Amoroso
Derek H Oakley
Brian J Wainger
Damian J Williams
David J Kahler
Mariko Yamaki
Lance Davidow
Christopher T Rodolfa
John T Dimos
Shravani Mikkilineni
Amy B MacDermott
Clifford J Woolf
Christopher E Henderson
Hynek Wichterle
Kevin Eggan

Funding

Research Training for AnesthetistsT32GM007592 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI STUART A FORMAN · 1985 to 2026
$11.8M
ALTERED SENSIBILITY FOLLOWING PERIPHERAL NERVE DAMAGER01NS038253 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WOOLF, CLIFFORD J · 1999 to 2017
$8.2M
Generation and Characterization of Amyotrophic Lateral Sclerosis iPS cellsRC2NS069395 · NINDS · JOHNS HOPKINS UNIVERSITY · PI CUDKOWICZ, MERIT E, EGGAN, KEVIN C · 2009 to 2010
$3.8M
Developmental Reprogramming after Nuclear TransferR01HD046732 · NICHD · HARVARD UNIVERSITY · PI EGGAN, KEVIN C · 2005 to 2013
$3.1M
Howard Hughes Medical InstituteNICHD NIH HHS R01 HD046732NIGMS NIH HHS 5T32GM007592NIGMS NIH HHS T32 GM007592NINDS NIH HHS 1RC2 NS069395-01NINDS NIH HHS R01 NS038253NINDS NIH HHS RC2 NS069395
6 · The paper itself

Abstract

Human induced pluripotent stem cells (iPSCs) present exciting opportunities for studying development and for in vitro disease modeling. However, reported variability in the behavior of iPSCs has called their utility into question. We established a test set of 16 iPSC lines from seven individuals of varying age, sex and health status, and extensively characterized the lines with respect to pluripotency and the ability to terminally differentiate. Under standardized procedures in two independent laboratories, 13 of the iPSC lines gave rise to functional motor neurons with a range of efficiencies similar to that of human embryonic stem cells (ESCs). Although three iPSC lines were resistant to neural differentiation, early neuralization rescued their performance. Therefore, all 16 iPSC lines passed a stringent test of differentiation capacity despite variations in karyotype and in the expression of early pluripotency markers and transgenes. This iPSC and ESC test set is a robust resource for those interested in the basic biology of stem cells and their applications.

Indexed as

Cell Culture TechniquesCell DifferentiationCells, CulturedFibroblastsHumansPluripotent Stem CellsSkinTissue Engineering

Identifiers

PMID21293464
PMCPMC3229307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.